Iso-XTend™
VHH albumin half-life extention
A humanised VHH antibody that binds to Human Serum Albumin with nanomolar affinities and can be easily combined with alternative VHH molecules
Iso-XTend™
A Valuable Addition for Antibody Therapeutics
Coupling of drugs to Human Serum Albumin offers the opportunity to control and fine-tune the pharmacokinetic qualities without altering functional activity of the antibody molecules.
Iso-XTend™ half life extension
- FcRn-mediated serum half-life extension
Enables small, felxible molecules
Avoids low affinity Fc Receptor binding
Easily formatted for versatile applications
VHH Features
Partnerships at Isogenica
Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including one clinical Phase II asset and numerous partnered pre-clinical and discovery programs.